Solute carrier family 22 member 6
Details
- Name
- Solute carrier family 22 member 6
- Synonyms
- hOAT1
- hPAHT
- hROAT1
- OAT1
- Organic anion transporter 1
- PAH transporter
- PAHT
- Renal organic anion transporter 1
- Gene Name
- SLC22A6
- Organism
- Humans
- Amino acid sequence
>lcl|BSEQ0037120|Solute carrier family 22 member 6 MAFNDLLQQVGGVGRFQQIQVTLVVLPLLLMASHNTLQNFTAAIPTHHCRPPADANLSKN GGLEVWLPRDRQGQPESCLRFTSPQWGLPFLNGTEANGTGATEPCTDGWIYDNSTFPSTI VTEWDLVCSHRALRQLAQSLYMVGVLLGAMVFGYLADRLGRRKVLILNYLQTAVSGTCAA FAPNFPIYCAFRLLSGMALAGISLNCMTLNVEWMPIHTRACVGTLIGYVYSLGQFLLAGV AYAVPHWRHLQLLVSAPFFAFFIYSWFFIESARWHSSSGRLDLTLRALQRVARINGKREE GAKLSMEVLRASLQKELTMGKGQASAMELLRCPTLRHLFLCLSMLWFATSFAYYGLVMDL QGFGVSIYLIQVIFGAVDLPAKLVGFLVINSLGRRPAQMAALLLAGICILLNGVIPQDQS IVRTSLAVLGKGCLAASFNCIFLYTGELYPTMIRQTGMGMGSTMARVGSIVSPLVSMTAE LYPSMPLFIYGAVPVAASAVTVLLPETLGQPLPDTVQDLESRWAPTQKEAGIYPRKGKQT RQQQEHQKYMVPLQASAQEKNGL
- Number of residues
- 563
- Molecular Weight
- 61815.78
- Theoretical pI
- 8.78
- GO Classification
- Functionschloride ion binding / inorganic anion exchanger activity / organic anion transmembrane transporter activity / sodium-independent organic anion transmembrane transporter activityProcessesalpha-ketoglutarate transport / anion transmembrane transport / organic anion transport / protein homooligomerization / renal tubular secretion / response to methotrexate / sodium-independent organic anion transport / transmembrane transportComponentsbasolateral plasma membrane / caveola / extracellular exosome / integral component of plasma membrane / plasma membrane / protein complex
- General Function
- Sodium-independent organic anion transmembrane transporter activity
- Specific Function
- Involved in the renal elimination of endogenous and exogenous organic anions. Functions as organic anion exchanger when the uptake of one molecule of organic anion is coupled with an efflux of one molecule of endogenous dicarboxylic acid (glutarate, ketoglutarate, etc). Mediates the sodium-independent uptake of 2,3-dimercapto-1-propanesulfonic acid (DMPS) (By similarity). Mediates the sodium-independent uptake of p-aminohippurate (PAH), ochratoxin (OTA), acyclovir (ACV), 3'-azido-3-'deoxythymidine (AZT), cimetidine (CMD), 2,4-dichloro-phenoxyacetate (2,4-D), hippurate (HA), indoleacetate (IA), indoxyl sulfate (IS) and 3-carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF), cidofovir, adefovir, 9-(2-phosphonylmethoxyethyl) guanine (PMEG), 9-(2-phosphonylmethoxyethyl) diaminopurine (PMEDAP) and edaravone sulfate. PAH uptake is inhibited by p-chloromercuribenzenesulphonate (PCMBS), diethyl pyrocarbonate (DEPC), sulindac, diclofenac, carprofen, glutarate and okadaic acid (By similarity). PAH uptake is inhibited by benzothiazolylcysteine (BTC), S-chlorotrifluoroethylcysteine (CTFC), cysteine S-conjugates S-dichlorovinylcysteine (DCVC), furosemide, steviol, phorbol 12-myristate 13-acetate (PMA), calcium ionophore A23187, benzylpenicillin, furosemide, indomethacin, bumetamide, losartan, probenecid, phenol red, urate, and alpha-ketoglutarate.
- Pfam Domain Function
- Sugar_tr (PF00083)
- Transmembrane Regions
- 10-30 136-156 165-187 191-213 225-245 249-269 338-358 369-389 396-416 426-446 456-475 485-505
- Cellular Location
- Cell membrane
- Gene sequence
>lcl|BSEQ0010747|Solute carrier family 22 member 6 (SLC22A6) ATGGCCTTTAATGACCTCCTGCAGCAGGTGGGGGGTGTCGGCCGCTTCCAGCAGATCCAG GTCACCCTGGTGGTCCTCCCCCTGCTCCTGATGGCTTCTCACAACACCCTGCAGAACTTC ACTGCTGCCATCCCTACCCACCACTGCCGCCCGCCTGCCGATGCCAACCTCAGCAAGAAC GGGGGGCTGGAGGTCTGGCTGCCCCGGGACAGGCAGGGGCAGCCTGAGTCCTGCCTCCGC TTCACCTCCCCGCAGTGGGGACTGCCCTTTCTCAATGGCACAGAAGCCAATGGCACAGGG GCCACAGAGCCCTGCACCGATGGCTGGATCTATGACAACAGCACCTTCCCATCTACCATC GTGACTGAGTGGGACCTTGTGTGCTCTCACAGGGCCCTACGCCAGCTGGCCCAGTCCTTG TACATGGTGGGGGTGCTGCTCGGAGCCATGGTGTTCGGCTACCTTGCAGACAGGCTAGGC CGCCGGAAGGTACTCATCTTGAACTACCTGCAGACAGCTGTGTCAGGGACCTGCGCAGCC TTCGCACCCAACTTCCCCATCTACTGCGCCTTCCGGCTCCTCTCGGGCATGGCTCTGGCT GGCATCTCCCTCAACTGCATGACACTGAATGTGGAGTGGATGCCCATTCACACACGGGCC TGCGTGGGCACCTTGATTGGCTATGTCTACAGCCTGGGCCAGTTCCTCCTGGCTGGTGTG GCCTACGCTGTGCCCCACTGGCGCCACCTGCAGCTACTGGTCTCTGCGCCTTTTTTTGCC TTCTTCATCTACTCCTGGTTCTTCATTGAGTCGGCCCGCTGGCACTCCTCCTCCGGGAGG CTGGACCTCACCCTGAGGGCCCTGCAGAGAGTCGCCCGGATCAATGGGAAGCGGGAAGAA GGAGCCAAATTGAGTATGGAGGTACTCCGGGCCAGTCTGCAGAAGGAGCTGACCATGGGC AAAGGCCAGGCATCGGCCATGGAGCTGCTGCGCTGCCCCACCCTCCGCCACCTCTTCCTC TGCCTCTCCATGCTGTGGTTTGCCACTAGCTTTGCATACTATGGGCTGGTCATGGACCTG CAGGGCTTTGGAGTCAGCATCTACCTAATCCAGGTGATCTTTGGTGCTGTGGACCTGCCT GCCAAGCTTGTGGGCTTCCTTGTCATCAACTCCCTGGGTCGCCGGCCTGCCCAGATGGCT GCACTGCTGCTGGCAGGCATCTGCATCCTGCTCAATGGGGTGATACCCCAGGACCAGTCC ATTGTCCGAACCTCTCTTGCTGTGCTGGGGAAGGGTTGTCTGGCTGCCTCCTTCAACTGC ATCTTCCTGTATACTGGGGAACTGTATCCCACAATGATCCGGCAGACAGGCATGGGAATG GGCAGCACCATGGCCCGAGTGGGCAGCATCGTGAGCCCACTGGTGAGCATGACTGCCGAG CTCTACCCCTCCATGCCTCTCTTCATCTACGGTGCTGTTCCTGTGGCCGCCAGCGCTGTC ACTGTCCTCCTGCCAGAGACCCTGGGCCAGCCACTGCCAGACACGGTGCAGGACCTGGAG AGCAGGTGGGCCCCCACTCAGAAAGAAGCAGGGATATATCCCAGGAAAGGGAAACAGACG CGACAGCAACAAGAGCACCAGAAGTATATGGTCCCACTGCAGGCCTCAGCACAAGAGAAG AATGGACTCTGA
- Chromosome Location
- 11
- Locus
- Not Available
- External Identifiers
Resource Link UniProtKB ID Q4U2R8 UniProtKB Entry Name S22A6_HUMAN GenBank Protein ID 3831566 GenBank Gene ID AF057039 GenAtlas ID hROAT1 HGNC ID HGNC:10970 - General References
- Reid G, Wolff NA, Dautzenberg FM, Burckhardt G: Cloning of a human renal p-aminohippurate transporter, hROAT1. Kidney Blood Press Res. 1998;21(2-4):233-7. [Article]
- Hosoyamada M, Sekine T, Kanai Y, Endou H: Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol. 1999 Jan;276(1 Pt 2):F122-8. [Article]
- Lu R, Chan BS, Schuster VL: Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C. Am J Physiol. 1999 Feb;276(2 Pt 2):F295-303. [Article]
- Race JE, Grassl SM, Williams WJ, Holtzman EJ: Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem Biophys Res Commun. 1999 Feb 16;255(2):508-14. [Article]
- Cihlar T, Lin DC, Pritchard JB, Fuller MD, Mendel DB, Sweet DH: The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. Mol Pharmacol. 1999 Sep;56(3):570-80. [Article]
- Bahn A, Prawitt D, Buttler D, Reid G, Enklaar T, Wolff NA, Ebbinghaus C, Hillemann A, Schulten HJ, Gunawan B, Fuzesi L, Zabel B, Burckhardt G: Genomic structure and in vivo expression of the human organic anion transporter 1 (hOAT1) gene. Biochem Biophys Res Commun. 2000 Aug 28;275(2):623-30. [Article]
- Taylor TD, Noguchi H, Totoki Y, Toyoda A, Kuroki Y, Dewar K, Lloyd C, Itoh T, Takeda T, Kim DW, She X, Barlow KF, Bloom T, Bruford E, Chang JL, Cuomo CA, Eichler E, FitzGerald MG, Jaffe DB, LaButti K, Nicol R, Park HS, Seaman C, Sougnez C, Yang X, Zimmer AR, Zody MC, Birren BW, Nusbaum C, Fujiyama A, Hattori M, Rogers J, Lander ES, Sakaki Y: Human chromosome 11 DNA sequence and analysis including novel gene identification. Nature. 2006 Mar 23;440(7083):497-500. [Article]
- Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article]
- Groves CE, Munoz L, Bahn A, Burckhardt G, Wright SH: Interaction of cysteine conjugates with human and rabbit organic anion transporter 1. J Pharmacol Exp Ther. 2003 Feb;304(2):560-6. [Article]
- Tanaka K, Xu W, Zhou F, You G: Role of glycosylation in the organic anion transporter OAT1. J Biol Chem. 2004 Apr 9;279(15):14961-6. Epub 2004 Jan 28. [Article]
- Hong M, Zhou F, You G: Critical amino acid residues in transmembrane domain 1 of the human organic anion transporter hOAT1. J Biol Chem. 2004 Jul 23;279(30):31478-82. Epub 2004 May 15. [Article]
- Srimaroeng C, Chatsudthipong V, Aslamkhan AG, Pritchard JB: Transport of the natural sweetener stevioside and its aglycone steviol by human organic anion transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8). J Pharmacol Exp Ther. 2005 May;313(2):621-8. Epub 2005 Jan 11. [Article]
- Tahara H, Shono M, Kusuhara H, Kinoshita H, Fuse E, Takadate A, Otagiri M, Sugiyama Y: Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney. Pharm Res. 2005 Apr;22(4):647-60. Epub 2005 Apr 7. [Article]
- Perry JL, Dembla-Rajpal N, Hall LA, Pritchard JB: A three-dimensional model of human organic anion transporter 1: aromatic amino acids required for substrate transport. J Biol Chem. 2006 Dec 8;281(49):38071-9. Epub 2006 Oct 11. [Article]
- Mizuno N, Takahashi T, Iwase Y, Kusuhara H, Niwa T, Sugiyama Y: Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate. Drug Metab Dispos. 2007 Aug;35(8):1429-34. Epub 2007 May 14. [Article]
- Bleasby K, Hall LA, Perry JL, Mohrenweiser HW, Pritchard JB: Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). J Pharmacol Exp Ther. 2005 Aug;314(2):923-31. Epub 2005 May 24. [Article]
- Xu G, Bhatnagar V, Wen G, Hamilton BA, Eraly SA, Nigam SK: Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)]. Kidney Int. 2005 Oct;68(4):1491-9. [Article]
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB00695 Furosemide approved, vet_approved unknown inhibitorinducer Details DB00936 Salicylic acid approved, investigational, vet_approved unknown inhibitor Details DB01032 Probenecid approved, investigational unknown substrateinhibitor Details DB00345 Aminohippuric acid approved, investigational unknown substrateinhibitor Details DB01009 Ketoprofen approved, vet_approved unknown inhibitor Details DB03553 Glutaric Acid experimental unknown substrateinhibitor Details DB00369 Cidofovir approved unknown substrateinhibitor Details DB01333 Cefradine approved unknown inhibitor Details DB00718 Adefovir dipivoxil approved, investigational unknown substrateinhibitor Details DB00554 Piroxicam approved, investigational unknown inhibitor Details DB03783 Phenacetin withdrawn unknown inhibitor Details DB00788 Naproxen approved, vet_approved unknown inhibitor Details DB00328 Indomethacin approved, investigational unknown substrateinhibitor Details DB01050 Ibuprofen approved unknown inhibitor Details DB00712 Flurbiprofen approved, investigational unknown inhibitor Details DB00749 Etodolac approved, investigational, vet_approved unknown inhibitor Details DB00861 Diflunisal approved, investigational unknown inhibitor Details DB00586 Diclofenac approved, vet_approved unknown inhibitor Details DB01597 Cilastatin approved, investigational unknown inhibitor Details DB01053 Benzylpenicillin approved, vet_approved unknown inhibitor Details DB04519 Caprylic acid investigational unknown inhibitor Details DB00501 Cimetidine approved, investigational unknown substrateinhibitor Details DB00168 Aspartame investigational, nutraceutical unknown inhibitor Details DB00759 Tetracycline approved, vet_approved, withdrawn unknown inhibitor Details DB00595 Oxytetracycline approved, investigational, vet_approved unknown substrateinhibitor Details DB01017 Minocycline approved, investigational unknown inhibitor Details DB00254 Doxycycline approved, investigational, vet_approved unknown inhibitor Details DB01004 Ganciclovir approved, investigational unknown inhibitor Details DB00787 Acyclovir approved unknown substrateinhibitor Details DB00917 Dinoprostone approved unknown substrateinhibitor Details DB00456 Cefalotin approved, investigational, vet_approved unknown inhibitor Details DB01212 Ceftriaxone approved unknown inhibitor Details DB00493 Cefotaxime approved unknown inhibitor Details DB01329 Cefoperazone approved, investigational unknown inhibitor Details DB01327 Cefazolin approved unknown substrateinhibitor Details DB01326 Cefamandole approved, experimental unknown inhibitor Details DB01140 Cefadroxil approved, vet_approved, withdrawn unknown inhibitor Details DB00812 Phenylbutazone approved, vet_approved unknown inhibitor Details DB00563 Methotrexate approved unknown substrateinhibitor Details DB00693 Fluorescein approved unknown substrateinhibitor Details DB00678 Losartan approved unknown inhibitor Details DB00999 Hydrochlorothiazide approved, vet_approved unknown substrateinhibitor Details DB00887 Bumetanide approved unknown substrateinhibitor Details DB00175 Pravastatin approved no inhibitor Details DB00520 Caspofungin approved unknown inhibitor Details DB00605 Sulindac approved, investigational unknown inhibitor Details DB00140 Riboflavin approved, investigational, nutraceutical, vet_approved unknown inhibitor Details DB00158 Folic acid approved, nutraceutical, vet_approved unknown inhibitor Details DB00584 Enalapril approved, vet_approved unknown inhibitor Details DB00821 Carprofen approved, vet_approved, withdrawn unknown inhibitor Details DB01197 Captopril approved unknown substrateinhibitor Details DB01124 Tolbutamide approved, investigational unknown inhibitor Details DB01060 Amoxicillin approved, vet_approved unknown inhibitor Details DB00567 Cephalexin approved, investigational, vet_approved unknown substrateinhibitor Details DB00313 Valproic acid approved, investigational unknown inhibitor Details DB00779 Nalidixic acid approved, investigational unknown inhibitor Details DB00903 Etacrynic acid approved, investigational unknown inhibitor Details DB00091 Cyclosporine approved, investigational, vet_approved unknown substrateinhibitor Details DB00703 Methazolamide approved unknown inhibitor Details DB00311 Ethoxzolamide withdrawn unknown inhibitor Details DB00606 Cyclothiazide approved unknown inhibitor Details DB00880 Chlorothiazide approved, vet_approved unknown inhibitor Details DB00819 Acetazolamide approved, vet_approved unknown inhibitor Details DB02266 Flufenamic acid approved unknown inhibitor Details DB00500 Tolmetin approved unknown inhibitor Details DB00945 Acetylsalicylic acid approved, vet_approved unknown inhibitor Details DB01435 Antipyrine approved, investigational unknown inhibitor Details DB03585 Oxyphenbutazone approved, withdrawn unknown inhibitor Details DB00939 Meclofenamic acid approved, vet_approved unknown inhibitor Details DB01424 Aminophenazone approved, withdrawn unknown inhibitor Details DB00731 Nateglinide approved, investigational unknown inhibitor Details DB00319 Piperacillin approved unknown inhibitor Details DB01165 Ofloxacin approved unknown inhibitor Details DB01059 Norfloxacin approved unknown inhibitor Details DB00607 Nafcillin approved, investigational unknown inhibitor Details DB00827 Cinoxacin approved, investigational, withdrawn unknown inhibitor Details DB00446 Chloramphenicol approved, vet_approved, withdrawn unknown inhibitor Details DB00438 Ceftazidime approved unknown inhibitor Details DB00578 Carbenicillin approved, investigational unknown inhibitor Details DB00432 Trifluridine approved, investigational unknown substrateinhibitor Details DB01016 Glyburide approved unknown inhibitor Details DB04348 Taurocholic acid approved, experimental unknown substrateinhibitor Details DB00529 Foscarnet approved unknown inhibitor Details DB00672 Chlorpropamide approved, investigational unknown inhibitor Details DB00229 Cefotiam approved, investigational unknown substrateinhibitor Details DB01051 Novobiocin approved, investigational, vet_approved, withdrawn unknown inhibitor Details DB00286 Conjugated estrogens approved unknown substrate Details DB02527 Cyclic adenosine monophosphate experimental unknown substrate Details DB00709 Lamivudine approved, investigational unknown substrate Details DB00365 Grepafloxacin approved, investigational, withdrawn unknown substrate Details DB00649 Stavudine approved, investigational unknown substrate Details DB00943 Zalcitabine approved, investigational unknown substrate Details DB00900 Didanosine approved unknown substrate Details DB01032 Probenecid approved, investigational yes inhibitor Details DB01237 Bromodiphenhydramine approved unknown Details DB01414 Cefacetrile experimental, vet_approved unknown substrateinhibitor Details DB00654 Latanoprost approved, investigational unknown substrateinhibitor Details DB00577 Valaciclovir approved, investigational unknown Details DB08843 GS 0573 investigational unknown Details DB00495 Zidovudine approved unknown substrate Details DB02315 Cyclic GMP experimental unknown Details DB08844 Uric acid investigational unknown Details DB01160 Dinoprost tromethamine approved, vet_approved unknown Details DB06151 Acetylcysteine approved, investigational unknown substrate Details DB08846 Ellagic acid investigational unknown substrateinhibitor Details DB04133 Degraded Cephaloridine experimental unknown Details DB00659 Acamprosate approved, investigational unknown substrate Details DB08912 Dabrafenib approved, investigational no inhibitor Details DB00300 Tenofovir disoproxil approved, investigational unknown substrate Details DB00493 Cefotaxime approved unknown Details DB01212 Ceftriaxone approved unknown Details DB01685 Topiroxostat experimental unknown inhibitor Details DB05016 Ataluren approved, investigational no inhibitor Details DB13874 Enasidenib approved, investigational unknown inhibitor Details DB08930 Dolutegravir approved no inhibitor Details DB12332 Rucaparib approved, investigational no inhibitor Details DB11817 Baricitinib approved, investigational unknown inhibitor Details DB00535 Cefdinir approved unknown substrate Details DB01415 Ceftibuten approved, investigational unknown substrate Details DB01332 Ceftizoxime approved, withdrawn unknown substrateinhibitor Details DB09008 Cefaloridine experimental, withdrawn unknown substrate Details DB00155 Citrulline investigational, nutraceutical unknown substrate Details DB12243 Edaravone approved, investigational no substrate Details DB00770 Alprostadil approved, investigational unknown substrateinhibitor Details DB09298 Silibinin experimental, investigational unknown substrateinhibitor Details DB09078 Lenvatinib approved, investigational unknown inhibitor Details DB01606 Tazobactam approved unknown substrateinhibitor Details DB01045 Rifampicin approved unknown inhibitor Details DB11751 Cabotegravir approved, investigational unknown inhibitor Details DB09213 Dexibuprofen approved, investigational unknown Details DB09299 Tenofovir alafenamide approved no substrate Details DB14126 Tenofovir experimental, investigational no substrate Details DB11757 Istradefylline approved, investigational unknown inhibitor Details DB15328 Ubrogepant approved, investigational unknown substrate Details DB00927 Famotidine approved no substrate Details DB11644 Tafamidis approved, investigational unknown inhibitor Details DB12466 Favipiravir approved, investigational unknown inhibitor Details DB11837 Osilodrostat approved, investigational unknown inhibitor Details DB00774 Hydroflumethiazide approved, investigational, withdrawn unknown substrateinhibitor Details DB01324 Polythiazide approved unknown substrate Details DB15822 Pralsetinib approved, investigational no inhibitor Details DB16628 Fosdenopterin approved unknown inhibitor Details DB00601 Linezolid approved, investigational no inhibitor Details DB12151 Brincidofovir approved, investigational no inhibitor Details DB12265 Fexinidazole approved, investigational unknown inhibitor Details DB16098 Atogepant approved, investigational no substrate Details DB06176 Romidepsin approved, investigational no inhibitor Details DB15413 Pafolacianine approved, investigational no substrate Details DB04847 Roxadustat approved, investigational unknown substrate Details DB17083 Linzagolix approved no inhibitor Details DB00642 Pemetrexed approved, investigational no substrate Details DB11682 Daprodustat approved, investigational no substrate Details DB01250 Olsalazine approved unknown upregulator Details DB12513 Omaveloxolone approved, investigational unknown inhibitor Details